Clinical Trial Update: Treatment Intermittent Periods Based on ctDNA-MRD（Circulating Tumor DNA-minimal Residual Disease） Status in Advanced HER2-Positive Breast Cancer

View source ↗

Summary

This is a clinical trial update about intermittent treatment periods guided by ctDNA-MRD status in advanced HER2-positive breast cancer. The trial is not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Breast Cancer | Status: NOT_YET_RECRUITING